These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 8313370

  • 1. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
    Tang DG, Diglio CA, Honn KV.
    Cancer Res; 1994 Feb 15; 54(4):1119-29. PubMed ID: 8313370
    [Abstract] [Full Text] [Related]

  • 2. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
    Honn KV, Tang DG, Grossi I, Duniec ZM, Timar J, Renaud C, Leithauser M, Blair I, Johnson CR, Diglio CA.
    Cancer Res; 1994 Jan 15; 54(2):565-74. PubMed ID: 8275495
    [Abstract] [Full Text] [Related]

  • 3. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis.
    Honn KV, Tang DG, Grossi IM, Renaud C, Duniec ZM, Johnson CR, Diglio CA.
    Exp Cell Res; 1994 Jan 15; 210(1):1-9. PubMed ID: 8269984
    [Abstract] [Full Text] [Related]

  • 4. Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid.
    Grossi IM, Fitzgerald LA, Umbarger LA, Nelson KK, Diglio CA, Taylor JD, Honn KV.
    Cancer Res; 1989 Feb 15; 49(4):1029-37. PubMed ID: 2492204
    [Abstract] [Full Text] [Related]

  • 5. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis.
    Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Shimoji K, Marnett LJ, Johnson CR, Honn KV.
    Cancer Res; 1994 Mar 15; 54(6):1574-9. PubMed ID: 7511046
    [Abstract] [Full Text] [Related]

  • 6. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
    Liu B, Marnett LJ, Chaudhary A, Ji C, Blair IA, Johnson CR, Diglio CA, Honn KV.
    Lab Invest; 1994 Mar 15; 70(3):314-23. PubMed ID: 8145526
    [Abstract] [Full Text] [Related]

  • 7. Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK).
    Tang DG, Tarrien M, Dobrzynski P, Honn KV.
    J Cell Physiol; 1995 Nov 15; 165(2):291-306. PubMed ID: 7593207
    [Abstract] [Full Text] [Related]

  • 8. 12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and alpha V beta 3 integrins.
    Tang DG, Diglio CA, Honn KV.
    Prostaglandins; 1993 Mar 15; 45(3):249-67. PubMed ID: 7683434
    [Abstract] [Full Text] [Related]

  • 9. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
    Chopra H, Timar J, Chen YQ, Rong XH, Grossi IM, Fitzgerald LA, Taylor JD, Honn KV.
    Int J Cancer; 1991 Nov 11; 49(5):774-86. PubMed ID: 1937964
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor.
    Tang DG, Chen YQ, Diglio CA, Honn KV.
    J Cell Biol; 1993 May 11; 121(3):689-704. PubMed ID: 7683691
    [Abstract] [Full Text] [Related]

  • 11. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells.
    Timar J, Tang D, Bazaz R, Haddad MM, Kimler VA, Taylor JD, Honn KV.
    Cell Motil Cytoskeleton; 1993 May 11; 26(1):49-65. PubMed ID: 8221907
    [Abstract] [Full Text] [Related]

  • 12. The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells.
    Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV.
    Exp Cell Res; 1993 Aug 11; 207(2):361-75. PubMed ID: 7688315
    [Abstract] [Full Text] [Related]

  • 13. 12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cells.
    Tang DG, Grossi IM, Chen YQ, Diglio CA, Honn KV.
    Int J Cancer; 1993 Apr 22; 54(1):102-11. PubMed ID: 8478136
    [Abstract] [Full Text] [Related]

  • 14. The lipoxygenase metabolite 12(S)-HETE promotes alpha IIb beta 3 integrin-mediated tumor-cell spreading on fibronectin.
    Timar J, Chen YQ, Liu B, Bazaz R, Taylor JD, Honn KV.
    Int J Cancer; 1992 Oct 21; 52(4):594-603. PubMed ID: 1399143
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor.
    Onoda JM, Kantak SS, Piechocki MP, Awad W, Chea R, Liu B, Honn KV.
    Radiat Res; 1994 Dec 21; 140(3):410-8. PubMed ID: 7972695
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE.
    Tang DG, Diglio CA, Bazaz R, Honn KV.
    J Cell Sci; 1995 Jul 21; 108 ( Pt 7)():2629-44. PubMed ID: 7593304
    [Abstract] [Full Text] [Related]

  • 17. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
    Haier J, Nasralla M, Nicolson GL.
    Br J Cancer; 1999 Aug 21; 80(12):1867-74. PubMed ID: 10471033
    [Abstract] [Full Text] [Related]

  • 18. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis.
    Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV.
    Biochem Biophys Res Commun; 1995 Jun 15; 211(2):462-8. PubMed ID: 7540838
    [Abstract] [Full Text] [Related]

  • 19. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
    Jain M, Ratheesh A, Gude RP.
    Chemotherapy; 2010 Jun 15; 56(1):82-8. PubMed ID: 20299795
    [Abstract] [Full Text] [Related]

  • 20. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
    Honn KV, Timár J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF.
    Exp Cell Res; 1994 Sep 15; 214(1):120-30. PubMed ID: 7521840
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.